article thumbnail

Treatment options for Crohn’s disease expand after Rinvoq approval

Pharmaceutical Technology

AbbVie anticipates Rinvoq sales to exceed $7.5bn in 2025 and for the peak revenues from both drugs to exceed Humira’s peak sales by 2027. The FDA has recommended that patients start with 45mg Rinvoq once daily for 12 weeks, with a maintenance dosage of 15mg following the 12-week period.

article thumbnail

WuXi STA breaks ground on new Delaware manufacturing facility

European Pharmaceutical Review

The second facility for WuXi STA in the US, Phase I of the new campus will provide formulation development, clinical and commercial drug product manufacturing services for a variety of oral and injectable dosage forms, as well as packaging, labelling, storage and distribution services for clinical trial materials and commercial drug products.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Getting Quality Supplements

The Thyroid Pharmacist

This is because I had learned about various adulterants found in supplements, how some supplement manufacturers don’t actually put the products that are on the label in the bottle, or that the dosages listed on the label may be completely different from what’s in the products. We have 270 expiring in March 2025.)

article thumbnail

MAPPing a New Route: FDA Updates MAPP on Suitability Petitions

The FDA Law Blog

Taking a step back, a Suitability Petition is used when an ANDA applicant wants to submit an ANDA that differs from its Reference Listed Drug in strength, dosage form, route of administration, or, in the case of a combination drug, active ingredient. Under 21 C.F.R.

FDA 59
article thumbnail

Jardiance for heart failure: How it works, effectiveness & more

The Checkup by Singlecare

Jardiance dosages for heart failure without diabetes While understanding the mechanism can seem complicated, the dosing of Jardiance for heart failure without diabetes is quite simple. Although there is no generic version of Jardiance available currently, there may be as early as 2025.

article thumbnail

Message from the Chair: Board Elections and Our Strategic Plan

ISPE

Jump ahead five years to 2023 and continuous manufacturing, especially in the solid dosage area, has moved forward, with numerous companies receiving product approvals from regulatory agencies. Regulatory agencies have kept pace with regulatory guidance to support these efforts as a result of great industry–regulatory collaboration.

Dosage 52
article thumbnail

Amarin Makes Moves towards Global Expansion of Vazkepa

Pharmaceutical Technology

In 2021, the WHO and the United Nations announced a plan to reduce premature mortality related to noncommunicable diseases, including cardiovascular disease, by 25% leading up to 2025. per 1,000mg dosage compared to Amarin’s $4.14 According to GlobalData, there are currently 135 therapeutics being developed for cardiovascular disease.